Literature DB >> 4344393

Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus.

J D Todd, F J Volenec, I M Paton.   

Abstract

Calves which had received avirulent infectious bovine rhinotracheitis virus (AV-IBR) by intranasal (IN) administration developed detectable levels of interferon (IF) in nasal secretions as early as 40 hr later. Peak titers (1:640) of IF appeared in secretions 72 to 96 hr after administration of virus, and titers of 1:80 to 1:320 were maintained through the 8th day. Lower titers (1:5 to 1:10) of IF were detected in sera obtained on the 4th to 8th days after administration of virus. Peak titers of IF in respiratory tract secretions were accompanied by a 100- to > 1,000-fold reduction in the levels of AV-IBR present in the secretions. Serum antibody was not detected prior to the 8th day after administration of AV-IBR. Calves which received AV-IBR by the IN route 72 or 96 hr earlier were refractory to challenge with virulent infectious bovine rhinotracheitis virus (IBR), whereas calves receiving AV-IBR 18 or 40 hr earlier became clinically ill following challenge. The temporal association between appearance of IF in respiratory tract secretions and onset of protection against challenge suggests a cause and effect relationship. No IF was detected in either nasal secretions or sera of calves receiving modified IBR virus by intramuscular injection. Following subsequent IN challenge of these calves, IF was detected in nasal secretions as early as 24 hr postchallenge and was maintained at titers of 1:40 to 1:80 for approximately 4 days, even in the absence of virus recovery. Greater ease of local IF induction with IBR virus in calves previously sensitized with that virus is suggested.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344393      PMCID: PMC422428          DOI: 10.1128/iai.5.5.699-706.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  MECHANISM OF RECOVERY FROM VIRAL INFECTION.

Authors:  S BARON
Journal:  Adv Virus Res       Date:  1963       Impact factor: 9.937

Review 2.  INTERFERON. A REVIEW AND ANALYSIS OF RECENT OBSERVATIONS.

Authors:  R R WAGNER
Journal:  Am J Med       Date:  1965-05       Impact factor: 4.965

3.  Interferon produced by cultures of calf kidney cells.

Authors:  D A TYRRELL
Journal:  Nature       Date:  1959-08-08       Impact factor: 49.962

4.  Viral interference in the brains of mice infected subcutaneously with herpes simplex virus.

Authors:  L W Catalano; J Moossy; S Sell
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

5.  Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

Authors:  R W Armstrong; M J Gurwith; D Waddell; T C Merigan
Journal:  N Engl J Med       Date:  1970-11-26       Impact factor: 91.245

6.  Production of circulating interferon in the bovine species.

Authors:  B D Rosenquist; R W Loan
Journal:  Am J Vet Res       Date:  1969-08       Impact factor: 1.156

7.  A respiratory syncytial virus of bovine origin.

Authors:  M F Paccaud; C Jacquier
Journal:  Arch Gesamte Virusforsch       Date:  1970

8.  Interferon production with strain SF-4 of parainfluenza-3 virus.

Authors:  B D Rosenquist; R W Loan
Journal:  Am J Vet Res       Date:  1967-05       Impact factor: 1.156

9.  Role of the spleen in interferon production in mice.

Authors:  M J Fruitstone; B S Michaels; D A Rudloff; M M Sigel
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

10.  Temporal relationship of interferon production and resistance to experimentally induced virus infection.

Authors:  R J Ash; H C Bubel
Journal:  J Infect Dis       Date:  1966-02       Impact factor: 5.226

View more
  16 in total

1.  Antiviral activity in interferon-treated bovine tracheal organ cultures.

Authors:  R W Fulton; S K Root
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

2.  [Influence of calves' age on a program of intranasal vaccination against infectious bovine rhinotracheitis and para-influenza 3].

Authors:  N Lapierre; S Larivière; G Marsolais
Journal:  Can Vet J       Date:  1975-03       Impact factor: 1.008

3.  Evaluation of the prophylactic potential of an immunomodulator against respiratory disease in calves.

Authors:  B Larsson; C Fossum; M Törnquist; P Matsson; S Alenius
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

4.  Interferon production by bovine tracheal organ cultures infected with bovid herpesvirus 1 strains.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1980-10

5.  Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1.

Authors:  L A Babiuk; M J Lawman; G A Gifford
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Bovine herpesvirus-1 and parainfluenza-3 virus interactions: clinical and immunological response in calves.

Authors:  A Ghram; P G Reddy; J L Morrill; F Blecha; H C Minocha
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

7.  Interferon, antibody responses and protection induced by an intranasal infectious bovine rhinotracheitis vaccine.

Authors:  M Savan; A B Angulo; J B Derbyshire
Journal:  Can Vet J       Date:  1979-08       Impact factor: 1.008

8.  Levels of interferon in blood serum and toxicity studies of bacteria-derived bovine alpha I1 interferon in dairy calves.

Authors:  J H Gillespie; F W Scott; C M Geissinger; C W Czarniecki; V T Scialli
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

9.  Fetal and adult bovine interferon production during bovine viral diarrhea virus infection.

Authors:  C R Rinaldo; D W Isackson; J C Overall; L A Glasgow; T T Brown; S I Bistner; J H Gillespie; F W Scott
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

10.  The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.

Authors:  K W Jericho; L A Babiuk
Journal:  Can J Comp Med       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.